Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (OX40) ligand

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 9665-9679

  Willett, Brian J ^a   McMonagle, Elizabeth L ^a   Logan, Nicola ^a   Spiller, O Brad ^b   Schneider, Pascal ^c   Hosie, Margaret J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7D6; MONOCLONAL ANTIBODY CD134; UNCLASSIFIED DRUG; CD134 ANTIGEN; MITOGENIC AGENT; OX40 LIGAND;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HELPER CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTIBODY AFFINITY; BIOSYNTHESIS; CAT; CAT DISEASE; CD4+ T LYMPHOCYTE; CELL LINE; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PROTEIN BINDING; RAT; VIROLOGY;

BACTERIA (MICROORGANISMS); FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; MURINAE; RATTUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; B-LYMPHOCYTES; CATS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHRONIC DISEASE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE EXPRESSION REGULATION; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MITOGENS; OX40 LIGAND; PROTEIN BINDING; RATS; RECEPTORS, OX40;

EID: 35348902002     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01020-07     Document Type: Article

References (40)

1. Ackley, C. D., J. K. Yamamoto, N. Levy, N. C. Pedersen, and M. D. Cooper. 1990. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. 1. Virol. 64:5652-5655.
2. Al Shamkhani, A., M. L. Birkeland, M. Puklavec, M. H. Brown, W. James, and A. N. Barclay. 1996. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 26:1695-1699.
3. + lymphokine-activated killer subset. J. Immunol. 150:17-30.
4. Bodmer, J. L., P. Schneider, and J. Tschopp. 2002. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27:19-26.
5. Bossen, C., K. Ingold, A. Tardivel, J. L. Bodmer, O. Gaide, S. Hertig, C. Ambrose, J. Tschopp, and P. Schneider. 2006. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281:13964-13971.
6. Cheney, C. M., J. L. Rojko, G. J. Kociba, M. L. Wellman, S. P. Di Bartola, L. J. Rezanka, L. Forman, and L. E. Mathes. 1990. A feline large granular lymphoma and its derived cell line. In Vitro Cell Dev. Biol. 26:455-463.
7. Compaan, D. M., and S. G. Hymowitz. 2006. The crystal structure of the costimulatory OX40-OX40L complex. Structure 14:1321-1330.
8. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
9. Dean, G. A., S. Himathongkham, and E. E. Sparger. 1999. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J. Virol. 73:2596-2603.
10. Dean, G. A., G. H. Reubel, P. F. Moore, and N. C. Pedersen. 1996. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J. Virol. 70:5165-5169.
11. de Parseval, A., U. Chatterji, G. Morris, P. Sun, A. J. Olson, and J. H. Elder. 2004. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat. Struct. Mol. Biol. 12:60-66.
12. + T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA 101:13044-13049.
13. de Parseval, A., S. Ngo, P. Sun, and J. H. Elder. 2004. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J. Virol. 78:9132-9143.
14. de Parseval, A., S. V. Su, J. H. Elder, and B. Lee. 2004. Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN. J. Virol. 78:2597-2600.
15. deParseval, A., and J. H. Elder. 2001. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75:4528-4539.
16. Durkop, H., U. Latza, P. Himmelreich, and H. Stein. 1995. Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues. Br. J. Haematol. 91:927-931.
17. English, R. V., C. M. Johnson, D. H. Gebhard, and M. B. Tompkins. 1993. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67:5175-5186.
18. + T cells. Immunol. Lett. 106:27-33.
19. Gorman, C. 1985. High efficiency gene transfer into mammalian cells, p. 143-190. In D. M. Glover (ed.), DNA cloning, vol. 2, a practical approach. IRL Press, Oxford, England.
20. Holler, N., A. Tardivel, M. Kovacsovics-Bankowski, S. Hertig, O. Gaide, F. Martinon, A. Tinel, D. Deperthes, S. Calderara, T. Schulthess, J. Engel, P. Schneider, and J. Tschopp. 2003. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell. Biol. 23:1428-1440.
21. + T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors. J. Virol. 79:4965-4976.
22. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30.
23. Miyazawa, T. M., T. Furuya, S. Itagaki, Y. Tohya, E. Takahashi, and T. Mikami. 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108:131-135.
24. r detected only on CD4 positive T blasts. Mol. Immunol. 24:1281-1290.
25. Pedersen, N. C. 1993. The feline immunodeficiency virus, p. 181-228. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, NY.
26. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency syndrome. Science 235:790-793.
27. + (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol. 126:697-703.
28. Sarrias, M. R., J. C. Whitbeck, I. Rooney, C. F. Ware, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 2000. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA. Mol. Immunol. 37:665-673.
29. Shimojima, M., T. Miyazawa, Y. Ikeda, E. L. McMonagle, H. Haining, H. Akashi, Y. Takeuchi, M. J. Hosie, and B. J. Willett. 2004. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303:1192-1195.
30. Spiller, O. B., L. Mark, C. E. Blue, D. G. Proctor, J. A. Aitken, A. M. Blom, and D. J. Blackbourn. 2006. Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J. Virol. 80:4068-4078.
31. Spiller, O. B., M. Robinson, E. O'Donnell, S. Milligan, B. P. Morgan, A. J. Davison, and D. J. Blackbourn. 2003. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 77:592-599.
32. Vahlenkamp, T. W., A. de Ronde, N. N. Schuurman, A. L. Van Vliet, J. van Drunen, M. C. Horzinek, and H. F. Egberink. 1999. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J. Gen. Virol. 80:2639-2646.
33. Vahlenkamp, T. W., E. J. Verschoor, N. N. M. P. Schuurman, A. L. W. van Vliet, M. C. Horzinek, H. F. Egberink, and A. de Ronde. 1997. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism. J. Virol. 71:7132-7135.
34. Willett, B. J., K. Adema, N. Heveker, A. Brelot, L. Picard, M. Alizon, J. D. Turner, J. A. Hoxie, S. Peiper, J. C. Neil, and M. J. Hosie. 1998. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J. Virol. 72:6475-6481.
35. Willett, B. J., C. A. Cannon, and M. J. Hosie. 2002. Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J. Virol. 76:9242-9252.
36. Willett, B. J., C. A. Cannon, and M. J. Hosie. 2003. Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. J. Virol. 77:709-712.
37. Willett, B. J., M. J. Hosie, J. C. Neil, J. D. Turner, and J. A. Hoxie. 1997. Common mechanism of infection by lentiviruses. Nature 385:587.
38. Willett, B. J., E. L. McMonagle, F. Bonci, M. Pistello, and M. J. Hosie. 2006. Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus. J. Virol. 80:7744-7747.
39. Willett, B. J., E. L. McMonagle, S. Ridha, and M. J. Hosie. 2006. Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus (FIV). J. Virol. 80:3386-3394.
40. Willett, B. J., L. Picard, M. J. Hosie, J. D. Turner, K. Adema, and P. R. Clapham. 1997. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:6407-6415.